Ann E Grow

Biopraxis, Inc.

$4,061,532

Attributed

$4,061,532

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY2005–07

$2M$1.5M$1M$500K$0

'05

'06

'07

Funding mix

By agency

NIH$4,061,532 · 5

By mechanism

R44$2,661,685 · 2

R43$1,399,847 · 3

Top collaborators

No co-investigators on record.

Most similar at Biopraxis, Inc.

Same institution · by research overlap

Peggy A Thompson$298,738

Others in their field

Top investigators on “Drug Screening /Evaluation”

Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
John C S Breitner · Johns Hopkins University$33,065,187
Philip J Disaia · University Of California Irvine$21,551,991
George R Painter · Chimerix, Inc.$19,230,662
Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
Stephen J Durako · Westat, Inc.$15,048,684

Research focus

Drug Screening /EvaluationDrug Discovery /IsolationTechnology /Technique DevelopmentDrug Design /Synthesis /ProductionRaman SpectrometryComputer Program /SoftwareLigandsHigh Throughput TechnologyHalobiphenyl /Halotriphenyl CompoundRna Directed Dna PolymeraseAntibioticsBiologicalBiological DatabasesBiological FactorsBinding (Molecular Function)Antiaids AgentAffinityBaseCell TypeCell PhysiologyCellular StructuresChemical GeneticsClinical Trials, Phase IArchitecture